NET CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Ipsen, Eisai Europe Limited, ITM and Boehringer Ingelheim.
NET CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Ipsen, Eisai Europe Limited, ITM and Boehringer Ingelheim
A medical oncologist and a patient advocate share their perspectives
PRRT and emerging strategies in neuroendocrine tumours
Maximising outcomes for patients with advanced neuroendocrine tumours
Medical experts discuss treatment optimisation and potential future developments
Medical experts discuss epidemiology, diagnosis, and referral strategies